January 15, 2019
Sales reps at Mitsubishi Tanabe Pharma were ramping up detailing calls at GPs for the company’s allergy drug Rupafin (rupatadine) in November ahead of the lifting of a 14-day prescription limit on December 1, market research firm Anterio’s “Impact Track”...read more